Financial News
All News about Olink Holding Ab [Publ] ADR
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
Olink reports fourth quarter and full year 2022 financial results
February 21, 2023
From Olink Proteomics AB
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Olink Holding's Earnings Outlook
February 20, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/03/manufacturing-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/stock_chart_lower.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image20.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/09/coffee_1600.jpg)
Where Olink Holding Stands With Analysts
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image31.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image_7.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/wall-street-sign-green-signal-up-day.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image-alcoa.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
From Olink Proteomics AB
Via GlobeNewswire
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image14.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
Olink to participate in the 41st Annual JP Morgan Healthcare Conference
December 29, 2022
From Olink Proteomics AB
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/25/image-credit_suisse.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
Olink reports third quarter 2022 financial results
November 10, 2022
From Olink Proteomics AB
Via GlobeNewswire
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
Olink to participate in November investor events
November 01, 2022
From Olink Proteomics AB
Via GlobeNewswire
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
![](https://ml.globenewswire.com/media/a14adc55-e7e7-441a-9810-60092c9a6a01/small/olink-proteomics-ab-png.png)
From Olink Proteomics AB
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/05/shortsqueeze1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/image30.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.